Buyouts remain a popular derisking strategy for defined benefit schemes. Aon Hewitt's Martin Bird looks at how the medically underwritten option is gaining ground in this burgeoning market.
We use
cookies
for a number of reasons, such as keeping Sites reliable and secure, personalising content and
ads, providing social media features and to analyse how our Sites are used.
